Probability Of Success In FDA Approval

This question practices how to think about drug development risk in healthcare valuation, especially the fact that not every pipeline asset has the same chance of reaching approval. Candidates need to understand that probability of success is a forecasting input, not a guaranteed outcome, and that it varies by therapeutic area and stage of development. Interviewers ask this because estimating risk adjusted revenue is a core skill when modeling clinical stage biotechnology companies, where future cash flows must be adjusted for regulatory uncertainty. It also tests whether you know how pipeline risk affects revenue forecasting and why analysts separate operating assumptions from development risk when building valuation models.